Indian Pharmaceuticals & Biotech Mid-Large Cap Stocks

Cohance Lifesciences

Market Cap: ₹269.4b

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India.

Eris Lifesciences

Market Cap: ₹201.9b

Provides domestic branded formulations for chronic and sub-chronic therapies in India.

Blue Jet Healthcare

Market Cap: ₹145.5b

Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.

Emcure Pharmaceuticals

Market Cap: ₹201.9b

Engages in the developing, manufacturing, and marketing pharmaceutical products worldwide.

Mankind Pharma

Market Cap: ₹1.1t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

Neuland Laboratories

Market Cap: ₹152.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Wockhardt

Market Cap: ₹208.5b

A pharmaceutical and biotech company, manufactures and trades pharmaceuticals, medicinal, botanical, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally.

OneSource Specialty Pharma

Market Cap: ₹182.0b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India and internationally.

Piramal Pharma

Market Cap: ₹276.6b

Operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally.

Akums Drugs and Pharmaceuticals

Market Cap: ₹87.8b

Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.